Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity.
We conducted a prospective longitudinal study to determine the nature and prevalence of cardiac abnormalities in systemic lupus erythematosus and to study their natural history and relationship with disease activity. Forty consecutive inpatients with systemic lupus erythematosus were studied during their admission and subsequently 6 to 12 months later. On each occasion a clinical cardiovascular examination was carried out, disease activity was scored using the "Lupus Activity Criteria Count" and a Doppler echocardiographic examination was carried out. 72.5% of patients had an abnormal echocardiogram in the first study while 51.7% were abnormal during the follow-up study. Valvar disease occurred in 37.5% of patients. The mitral valve was most commonly affected. Libman-Sacks endocarditis was rare (2.5%). Pericardial effusions were seen in 36.2% of echocardiograms. The majority (76.0%) of these were associated with hypoalbuminaemia. 80.0% of patients had active disease during the first examination and 41.4% at follow-up. There was no correlation between activity of disease and prevalence of cardiac abnormalities at either examination. We conclude that cardiac disease is common in systemic lupus erythematosus. Prevalence of cardiac abnormality did not correlate with disease activity.
Ong
M L
ML
Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Veerapen
K
K
Chambers
J B
JB
Lim
M N
MN
Manivasagar
M
M
Wang
F
F
D000293:Adolescent; D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000097:blood; D015150:Echocardiography, Doppler; D005260:Female; D006331:Heart Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000503:physiopathology; D008296:Malaysia / Q000453:epidemiology; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology; D015995:Prevalence; D011446:Prospective Studies; D013997:Time Factors
D000888:Antibodies, Anti-Idiotypic; D010743:Phospholipids